| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |